• Skip to main content

Regenerative Evidence Guide

Separate promising research from proven care.

  • Home
  • Start Here
  • How We Research
  • Editorial Policy
  • About
  • Contact

Eligibility Criteria in a Clinical Trial: What Inclusion and Exclusion Terms Mean

posted on September 10, 2026

By the Regenerative Evidence Guide Team

What “Eligibility Criteria” Means

Every public clinical trial record lists eligibility criteria — the requirements researchers use to decide who can join a study. Reading this section will not tell you whether you personally qualify. It will tell you what the study is designed to test and give you a specific list of questions for a clinician or study contact.

Key Terms to Know

  • Eligibility criteria: The full set of requirements — both inclusion and exclusion — that a study uses to decide who can enroll.
  • Inclusion criteria: The characteristics a person must have to be considered for the study, such as an age range, a diagnosis, or a disease stage.
  • Exclusion criteria: The characteristics that would keep a person out of the study, even if they meet every inclusion requirement.
  • Study record: The public page on a trial registry that describes a study’s design, status, locations, and eligibility criteria.
  • Screening: The formal process, run by the study team, that checks a specific person against the criteria. Reading a study record is not the same as being screened.

Are Inclusion and Exclusion Criteria Just Opposites?

Not usually. Inclusion criteria describe the population the researchers want to study — for example, adults within a certain age range who have a specific diagnosis. Exclusion criteria then narrow that group further, often to protect safety or to keep outside factors from affecting the results.

A person could meet every inclusion requirement and still be excluded for a separate reason, such as taking a medication that might interact with the study treatment, having a second condition the study wasn’t designed to handle, or being pregnant. That doesn’t reflect a flaw in the person — it reflects the narrow conditions a study needs to answer its research question.

Where to Find Eligibility Criteria in a Public Study Record

  1. Locate the study on a public registry. Search by condition, treatment type, or study ID number.
  2. Open the study record and find the “Eligibility Criteria” section. This is typically listed separately from the study description and results sections.
  3. Check the basic filters first. These usually include an age range, whether the study accepts “healthy volunteers” or only people with a specific condition, and sometimes a sex requirement.
  4. Read the full inclusion criteria list. This is often more detailed than the summary filters — for example, a specific stage of disease, a prior treatment history, or a minimum time since a previous procedure.
  5. Read the full exclusion criteria list. Note anything that applies to your situation, such as other conditions, medications, or recent procedures.
  6. Check the study status and contact information. A study can be listed but not yet recruiting, actively recruiting, or closed. The record should show a contact for enrollment questions.
  7. Write down anything unclear. Eligibility language is often written in clinical terms. Flag words you don’t recognize instead of guessing at their meaning.

What If You Might Not Qualify?

Not qualifying for one trial doesn’t mean no options exist. If you meet the inclusion criteria but see an exclusion criterion that might apply to you, ask the study contact about that specific line before assuming you’re out — some exclusions depend on details a record can’t fully capture. If you don’t meet the inclusion criteria at all, ask your clinician whether other studies, or a separate pathway, might fit.

One such pathway: for serious or life-threatening conditions, the FDA’s expanded access process allows a physician to request an investigational drug for an individual patient outside of a clinical trial, under its own federal requirements. This is decided case by case between a physician, the drug’s sponsor, and the FDA — it’s a conversation to start with a treating clinician, not something to pursue from a registry listing alone. For more on how this differs from a study, see the FDA’s page on understanding investigational drugs.

Questions to Bring to a Clinician or the Study Contact

  • Which specific inclusion or exclusion criterion is the one in question for me?
  • Is there a waiting period, a washout period, or a retest that could change my eligibility later?
  • Who makes the final eligibility decision, and at what point in the process?
  • If I’m not eligible for this study, are there other studies or expanded access options worth asking about?
  • What would formal screening involve, and what would it require of me?

Frequently Asked Questions

What’s the real difference between inclusion and exclusion criteria?

Inclusion criteria define who the study is designed for — the population researchers want to include. Exclusion criteria define reasons someone from that population would still be left out, often for safety or to protect the reliability of the results. They work together, not as simple opposites.

If I meet the inclusion criteria, am I guaranteed a spot?

No. Meeting inclusion criteria only means you match the basic population the study wants. You can still be ruled out by an exclusion criterion, and final eligibility is confirmed only through formal screening by the study team.

What should I do if I don’t seem to qualify for a trial?

Bring the specific criterion in question to your clinician or the study’s listed contact rather than assuming you’re disqualified. Ask about other studies that might fit, and ask whether a separate pathway, such as expanded access, is relevant to your situation.

Where exactly on a study record do I find this information?

Public study records list eligibility under a dedicated “Eligibility Criteria” section, separate from the study description and results. It typically includes basic filters like age and health status, followed by more detailed inclusion and exclusion lists.

Limits of This Guide

This guide explains how eligibility criteria are structured and where to find them in a public study record. It cannot tell you whether you personally qualify for any study, and it is not a substitute for a conversation with the study team or your own clinician. Eligibility language, criteria, and study status can all change as a trial progresses.

Medical information disclaimer: This article is for general education only and does not provide medical advice, diagnosis, or treatment recommendations. Eligibility for any specific clinical trial can only be determined by that study’s research team. If you have an urgent medical concern, contact your clinician or local emergency services. See our full medical information disclaimer for more detail.

This publication does not run in-house trials or provide treatment; you can read more about our sourcing approach on the How We Research page, or start with our Start Here guide.

By Regenerative Evidence Guide Editorial Team. Sources: ClinicalTrials.gov, How to Read a Study Record; FDA, Understanding Investigational Drugs. Last updated September 11, 2026.

Filed Under: regenerative medicine evidence

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Regenerative Evidence Guide

Separate promising research from proven care.

Topics

  • Start Here
  • Regulatory Status and Clinic Claims
  • Clinical Trial Records and Participation
  • Reading Study Evidence
  • Safety, Costs, and Procedure Planning

Publication

  • About
  • Editorial Policy
  • Review Process
  • Corrections
  • Independence Notice
  • Contact

Policies

  • Privacy Policy
  • Terms of Use
  • Medical Disclaimer
  • Affiliate Disclosure
  • Accessibility

Formal operator details are scheduled for policy completion by October 5, 2026. Regenerative Evidence Guide is an independent editorial publication at RegenerativeAcademy.com. It is not affiliated with the former academy, faculty, conferences, clinics, or training programs and offers no treatment, credential, or continuing education.

© 2026 Regenerative Evidence Guide